3 Health Care Stocks Driving The Sector Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 54 points (0.3%) at 18,054 as of Thursday, June 11, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,776 issues advancing vs. 1,216 declining with 167 unchanged.

The Health Care sector currently is unchanged today versus the S&P 500, which is up 0.2%. Top gainers within the sector include Healthsouth ( HLS), up 9.0%, Baxter International ( BAX), up 3.1%, Alnylam Pharmaceuticals ( ALNY), up 2.1%, Amgen ( AMGN), up 1.6% and Abbott Laboratories ( ABT), up 1.1%. On the negative front, top decliners within the sector include Opko Health ( OPK), down 2.5%, and Regeneron Pharmaceuticals ( REGN), down 1.5%.

TheStreet would like to highlight 3 stocks pushing the sector higher today:

3. Teva Pharmaceutical Industries ( TEVA) is one of the companies pushing the Health Care sector higher today. As of noon trading, Teva Pharmaceutical Industries is up $0.49 (0.8%) to $61.09 on light volume. Thus far, 1.1 million shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 5.4 million shares. The stock has ranged in price between $60.74-$61.39 after having opened the day at $60.78 as compared to the previous trading day's close of $60.60.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines. Teva Pharmaceutical Industries has a market cap of $50.9 billion and is part of the drugs industry. Shares are up 5.4% year-to-date as of the close of trading on Wednesday. Currently there are 9 analysts who rate Teva Pharmaceutical Industries a buy, 1 analyst rates it a sell, and 9 rate it a hold.

TheStreet Ratings rates Teva Pharmaceutical Industries as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations, expanding profit margins, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Teva Pharmaceutical Industries Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Dollar Tree CEO Calls It Quits, Joining List of Executive Departures This Year

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

S&P 500 and Dow Aim for New Records With Broad-Based Gains Ahead of Fed

Dow and S&P 500 Reach New Intraday Highs With Markets in Good Mood Ahead of Fed